510(k) device
ARK Levetiracetam II Assay
Ark Diagnostics, Inc. · Levetiracetam Assay (ORI, Class II) · First FDA decision Nov 2, 2009, newest Feb 27, 2024Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
2
Naming "ARK"
MAUDE reports
1
Brand "ARK", since 2015
PubMed studies
1,104
Mentioning "ARK"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ARK Levetiracetam II Assay
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K232522 · Decided Feb 27, 2024 · 193 days after receipt
Device type: Levetiracetam Assay (ORI) · Laboratory Medicine & Pathology
K091653 · Decided Nov 2, 2009 · 146 days after receipt
Device type: Levetiracetam Assay (ORI) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Deep Brain Stimulation for Essential Tremor and Parkinson’s DiseaseNational determinationOn the books160.24Updated Nov 4, 2026
- Screening for Colorectal Cancer-Non-Invasive Biomarker TestsNational analysisReview closedCAG-00440RUpdated Sep 22, 2026
- Screening for Colorectal Cancer - Blood-Based Biomarker TestsNational analysisReview closedCAG-00454NUpdated Sep 22, 2026
- Deep Brain Stimulation for Parkinson's DiseaseNational analysisReview closedCAG-00124NUpdated Sep 14, 2026
- ProMark® Risk ScoreLocal determinationIn effectL36675CGS Administrators, LLCUpdated Nov 5, 2026
- Urine-based Biomarkers in Patients with MicrohematuriaLocal determinationTakes effect soonL40380First Coast Service Options, Inc.Updated Oct 30, 2026
- Urine-based Biomarkers in Patients with MicrohematuriaLocal determinationTakes effect soonL40378Novitas Solutions, Inc.Updated Oct 30, 2026
- MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal CarcinomaProposed local determinationProposedDL40470WPS Insurance CorporationUpdated Sep 17, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "ARK", any status and sponsor, newest update first.
Ebers Medical Technology, S.L.Not on our public-company list
NCT05175885 · 100 participants (planned) · Start Dec 14, 2023 · Primary completion Dec 2027
Device: Ex vivo normothermic perfusion; Cold preservation · For: Kidney Transplantation
Sites: Zaragoza, Spain
- Access Cannulation Trial IIRecruiting
Voyager BiomedicalNot on our public-company list
NCT05490225 · 100 participants (planned) · Start Apr 23, 2025 · Primary completion Mar 25, 2027
Device: VenaSure · For: Dialysis; Complications; Vascular Access Complication
Sites: Dothan, Alabama; Riverside, California; Boston, Massachusetts · 8 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ARK", and for the whole product code for context.
This brand
1 reports: 1 malfunction, 0 injury, 0 death
Whole product code ORI
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
- ARK-10000Malfunction
3002807715-2016-00032 · Received Aug 12, 2016 · Event dated Jul 14, 2016
Device type: Refractometer, Ophthalmic (HKO)
Device problem as coded: Smoking
Patient problem as coded: No Known Impact Or Consequence To Patient
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ARK"[tiab]. The summary above synthesizes these.
- Animal Ark.
Foyster G · Nature · 2024News
- From the lost ark to archaeogenetics.
Roberts A · Lancet · 2024
- Linguistics. Noam's Ark.
Bever T, Montalbetti M · Science · 2002Comment
- Cloning Noah's ark.
Lanza RP, Dresser BL, Damiani P · Sci Am · 2000Review
- G-protein-coupled receptor kinases.
Palczewski K, Benovic JL · Trends Biochem Sci · 1991Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- [An immunological Noah's Ark].
Buzoni-Gatel D, Kourilsky P · Med Sci (Paris) · 2009Editorial
- The receptor-like kinase ARK controls symbiotic balance across land plants.
Sgroi M, Hoey D, Medina Jimenez K, et al. · Proc Natl Acad Sci U S A · 2024Research Support, N.I.H., Extramural
- Sailing on the ark of Scopus: Narra J new journey.
Wendt GW, Wagner AL, Dhama K, et al. · Narra J · 2023Editorial
- Foundation Ark: Accruing and Reusing Knowledge for Superior and Robust Performance.
Ma D, Pang J, Gotway MB, et al. · Med Image Comput Comput Assist Interv · 2023
- Anti-inflammatory action of ark shell (Scapharca subcrenata) protein hydrolysate in LPS-stimulated RAW264.7 murine macrophages.
Marasinghe CK, Jung WK, Je JY · J Food Biochem · 2022Research Support, Non-U.S. Gov't
- ARK-1 inhibits EGFR signaling in C. elegans.
Hopper NA, Lee J, Sternberg PW · Mol Cell · 2000Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- Performance of Fentanyl Immunoassays in an ED Patient Population.
Mills CM, Dryja PC, Champion-Lyons E, et al. · J Appl Lab Med · 2024Research Support, Non-U.S. Gov't
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.